Medication info
Sumatriptan 50 mg Tablet (Sumatriptan Succinate)

Sumatriptan 50 mg Tablet (Sumatriptan Succinate)

Prescription medicationTablet경구
Ingredient · strength
Sumatriptan Succinate›70mg / 1 tablet
Manufacturer / importer
명인제약(주)
Appearance
Pink oval film-coated tablet
Packaging
6 tablets (6 tablets/PETx1), 12 tablets (6 tablets/PETx2)
Approval status
Active

MFDS item code 200808280 · Notified 2008.07.31 · Insurance code 651902580

Summary

Main use
Quick relief of migraines (including aura, related to menstrual cycle)
Who takes it
Adults · Children
Adult dose
Administer 50 mg orally as sumatriptan at once. In a small number of patients, a dose of 100 mg may be necessary. If symptoms reappear after the initial dose, it can be reapplied, but the dosing interval should be at least 2 hours apart, and it must not exceed 300 mg in any 24-hour period. The same dose should not be reapplied for the same attack if there is no response to the prescribed amount.
Child dose
The safety and efficacy of this drug have not yet been established in children and adolescents under 18 years of age.

Ingredients

Manufacturer
명인제약(주)

Efficacy & effects

Quick relief of migraines (including aura, related to menstrual cycle)

  • Migraine aura
  • migraine
View approved original text

This medication helps to rapidly relieve migraines, whether or not accompanied by aura. It is also effective for migraines associated with the menstrual cycle, quickly reducing symptoms. Therefore, it is used to improve various types of migraines.

How to take

Adult dose

Administer 50 mg orally as sumatriptan at once. In a small number of patients, a dose of 100 mg may be necessary. If symptoms reappear after the initial dose, it can be reapplied, but the dosing interval should be at least 2 hours apart, and it must not exceed 300 mg in any 24-hour period. The same dose should not be reapplied for the same attack if there is no response to the prescribed amount.

Child dose

The safety and efficacy of this drug have not yet been established in children and adolescents under 18 years of age.

Precautions

This medication should not be used in patients with certain diseases or conditions. For example, it must not be administered if there is an allergy to this drug or its components. Additionally, it may pose risks for patients with heart disease, uncontrolled blood pressure, or severely impaired liver or kidney function. It should not be administered to pregnant or breastfeeding women, or to children or adolescents under 18 years of age. This drug is intended solely for migraine treatment and is not suitable for other types of headaches or neurological disorders. Caution is necessary when driving or operating machinery due to possible drowsiness after taking this medication. Even if there is no history of heart disease, the heart condition should be carefully assessed before use. Patients with liver or kidney dysfunction should use this medication cautiously under medical guidance. When taking with other drugs, potential drug interactions may occur, so it's essential to consult with a doctor or pharmacist. In case of overdose, immediate medical attention is required, and self-treatment can be dangerous. Store in a cool place out of the reach of children, and it is recommended not to transfer to another container.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory disturbances accompanied by cough and fever, jaundice (skin or eyes turn yellow), profound fatigue throughout the body, sudden and very severe headache, thunderclap headache, seizures, disorientation, visual disturbances, paralysis, urination issues

Mild side effects

Pain, throbbing sensation, warmth, coldness, pressure sensation, sensation of pressure in certain body parts, flushing, dizziness, weakness, fatigue, drowsiness, spasms, sensory disturbances, sensory loss, phonophobia, photophobia, confusion, depression, decreased concentration, olfactory disturbances, speech difficulties, unusual euphoria, facial pain, heat sensitivity, coordination problems, tearing, unilateral paralysis, sleep disturbances, fainting, tremors, aggression, apathy, cluster headache, decreased appetite, drug toxicity, tension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. By storing it this way, the drug's effectiveness can be maintained for a long period and used safely.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

6 tablets (6 tablets/PETx1), 12 tablets (6 tablets/PETx2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.